PD-1 is a key immune-checkpoint receptor expressed by activated T cells which mediates the immunosuppression, there are also reports that expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy [23]. The gene discussed is CD8A; the disease is neoplasm.